Metformin off label uses
Searched over 200M research papers
Summary
10 papers analyzed
These studies suggest metformin's off-label uses include reducing cardiovascular risks, aiding in weight management, improving reproductive health, potentially lowering cancer incidence, and offering cardioprotective benefits.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Off-Label Uses of Metformin: A Comprehensive Overview
Metformin in Type 1 Diabetes
Reducing Insulin Requirements and Cardiovascular Risks
Metformin, traditionally used for type 2 diabetes, is increasingly being used off-label in type 1 diabetes to reduce insulin requirements. Recent findings from the REMOVAL trial indicate that metformin can help reduce atherosclerosis progression, weight, and LDL-cholesterol levels in type 1 diabetes patients, potentially lowering long-term cardiovascular risks.
Metformin for Polycystic Ovary Syndrome (PCOS)
Hormonal and Metabolic Benefits
Metformin is a widely recognized off-label treatment for PCOS, primarily due to its insulin-sensitizing properties. It is used to manage symptoms such as hirsutism, acne, and insulin resistance. Studies have shown that metformin can improve ovulation rates and may reduce the risk of ovarian hyperstimulation syndrome during IVF/ICSI cycles . However, gastrointestinal side effects are common, which can limit its use.
Metformin in Obesity and Insulin Resistance
Adolescents and Long-Term Efficacy
Metformin is frequently prescribed off-label to treat obesity and insulin resistance in adolescents. Long-term studies indicate that while metformin can initially reduce BMI and insulin resistance, its effects may not be sustained over prolonged periods. Compliance and dosage issues are potential factors affecting its long-term efficacy .
Metformin in Cancer Prevention and Treatment
Antitumor Activity
Emerging research suggests that metformin may have antitumor properties. Population studies have indicated a lower incidence and mortality rate of cancer in diabetic patients using metformin. Its potential mechanisms include the inhibition of the PI3K/AKT/mTOR pathway, which is crucial in cancer cell growth and survival. Ongoing clinical trials are exploring metformin's role as a chemopreventive or adjuvant therapy in various cancers .
Metformin in Cardiovascular Health
Cardioprotective Effects
Metformin has shown promise in reducing cardiovascular risks beyond its glucose-lowering effects. It has been associated with a lower risk of myocardial infarction and congestive heart failure in diabetic patients. These benefits are thought to be mediated through mechanisms such as increased AMPK phosphorylation and enhanced nitric oxide production, which improve endothelial function and myocardial remodeling.
Metformin in Pregnancy and Gestational Diabetes
Safety and Efficacy
Metformin is also used off-label to manage gestational diabetes mellitus (GDM), particularly in overweight and obese women. Studies have demonstrated that metformin is safe during pregnancy and can result in less maternal weight gain compared to insulin. Additionally, children born to mothers treated with metformin have shown lower visceral fat accumulation, potentially reducing their risk of insulin resistance later in life.
Conclusion
Metformin's off-label uses extend far beyond its primary role in managing type 2 diabetes. From improving cardiovascular health and aiding in cancer prevention to managing PCOS and obesity, metformin's diverse applications highlight its potential as a multifaceted therapeutic agent. However, the long-term efficacy and safety of these off-label uses require further investigation to optimize treatment protocols and patient outcomes.
Sources and full results
Most relevant research papers on this topic
